实用肝脏病杂志 ›› 2024, Vol. 27 ›› Issue (4): 579-582.doi: 10.3969/j.issn.1672-5069.2024.04.022

• 肝硬化 • 上一篇    下一篇

CT参数联合FIB-4和血清VEGF水平预测乙型肝炎肝硬化患者并发食管静脉曲张效能分析*

汤泽宇, 顾菲, 周健文, 姜小兰, 毛雨婧, 樊琦   

  1. 224200 江苏省东台市人民医院影像科(汤泽宇,樊琦,周健文,姜小兰);检验科(顾菲),南通大学附属肿瘤医院影像科(毛雨婧 )
  • 收稿日期:2023-09-20 出版日期:2024-07-10 发布日期:2024-07-10
  • 通讯作者: 樊琦,E-mail:xinjie22022@163.com
  • 作者简介:汤泽宇,男,30岁,医学硕士,主治医师。E-mail:a929211795@163.com
  • 基金资助:
    *中国医药卫生事业发展基金会科研基金资助项目(编号:C202212-009);东台市医疗卫生领域科技计划项目(DTYW2023006)

Diagnostic efficacy of CT parameters and FIB-4 and serum VEGF levels in predicting esophageal varices in patients with hepatitis B-induced liver cirrhosis

Tang Zeyu, Gu Fei, Zhou Jianwen, et al   

  1. Department of Radiology, People's Hospital, Dongtai 224200, Jiangsu Province, China
  • Received:2023-09-20 Online:2024-07-10 Published:2024-07-10

摘要: 目的 分析应用X线计算机断层摄影(CT)检测参数联合纤维化-4因子(FIB-4)和血清血管内皮生长因子(VEGF)水平预测乙型肝炎肝硬化患者食管静脉曲张(EV)的效能。方法 2020年3月~2023年4月我院收治的乙型肝炎肝硬化患者98例,均接受胃镜检查诊断EV。行CT检查,采用层切法勾画,应用liver volume软件测量肝脏和脾脏体积,并测量门静脉内径(MPV)、脾静脉内径(SPV)和胃左静脉直径(LGV)。常规检测血小板计数和血生化指标,计算FIB-4,采用ELISA法检测血清VEGF水平,绘制受试者工作特征曲线(ROC),依据曲线下面积(AUC)判定指标联合预测EV的效能。结果 在本组肝硬化患者中,胃镜检查发现并发EV者48例;EV组脾脏体积、MPV和LGV分别为(581.7±98.6)cm3、(15.2±1.3)mm和(6.1±0.5)mm,显著大于无EV组【分别为(452.6±84.9)cm3、(12.1±0.8)mm和(4.2±0.3)mm,P<0.05】; EV组FIB-4和血清VEGF水平分别为(6.0±1.3)和(101.7±28.1)ng/L,显著高于无EV组【分别为(4.3±0.9)和(65.7±15.7)ng/L,P<0.05】;应用脾脏体积、MPV、LGV、FIB-4和血清VEGF水平联合预测EV存在的AUC为0.967(95% CI为0.931~0.997),其敏感度和特异度分别为91.8%和90.0%,显著优于指标单独预测(P<0.05)。结论 应用CT参数联合FIB-4和血清VEGF水平预测肝硬化患者发生EV具有较高的诊断效能。

关键词: 肝硬化, 食管静脉曲张, 脾脏体检, 肝纤维化-4因子, 血管内皮生长因子, 诊断

Abstract: Objective The purpose of this study was to investigate the diagnostic performance of computed tomography (CT)-detected parameters and fibrosis-4 (FIB-4) and serum vascular endothelial growth factor (VEGF) levels in predicting esophageal varices (EV) in patients with hepatitis B-induced liver cirrhosis (LC). Methods 98 patients hepatitis B-induced LC were admitted to our hospital between March 2020 and April 2023, and all patients underwent gastroscopy to find EV. The CT examination was conducted to measure the liver and spleen volumes, and the main portal vein (MPV), the splenic vein (SPV) and the left gastric vein (LGV) diameters. The FIB-4 was calculated, and serum VEGF levels were measured by ELISA. The receiver operating characteristic (ROC) curve was plotted, and the diagnostic performance was evaluated based on the area under the curve (AUC). Results Out of the 98 patients with LC in our series, the gastroscopy found EV in 48 cases; the volume of spleen, the MPV and the LGV in patients with EV were (581.7±98.6)cm3, (15.2±1.3)mm and (6.1±0.5)mm, all significantly higher than [(452.6±84.9)cm3, (12.1±0.8)mm and (4.2±0.3)mm, respectively, P<0.05] in those without EV; the FIB-4 score and serum VEGF level were (6.0±1.3) and (101.7±28.1)ng/L, both significantly higher than [(4.3±0.9) and (65.7±15.7)ng/L, P<0.05] in patients without EV; the AUC was 0.967(95% CI:0.931-0.997), with sensitivity of 91.8% and the specificity of 90.0%, when the combination of the spleen volume, MPV, LGV, FIB-4 and serum VEGF level was applied to predict the existence of EV. Conclusion The CT measured parameters of portal veins and FIB-4 and serum VEGF levels in predicting EV in patients with LC could achieve a promising diagnosing performance, which might help the clinicians make an appropriate managements.

Key words: Liver cirrhosis, Esophageal varices, Spleen volume, Fibrosis-4, Vascular endothelial growth factor, Diagnosis